HUT64232A - Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it - Google Patents

Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it

Info

Publication number
HUT64232A
HUT64232A HU9300069A HU9300069A HUT64232A HU T64232 A HUT64232 A HU T64232A HU 9300069 A HU9300069 A HU 9300069A HU 9300069 A HU9300069 A HU 9300069A HU T64232 A HUT64232 A HU T64232A
Authority
HU
Hungary
Prior art keywords
production
medical
extraction
prepartives
tanacetum parthenium
Prior art date
Application number
HU9300069A
Other languages
English (en)
Other versions
HU9300069D0 (en
Inventor
Norbert Dr Beuscher
Ingo Dr Willigmann
Original Assignee
Schaper & Bruemmer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6450610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT64232(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schaper & Bruemmer Gmbh filed Critical Schaper & Bruemmer Gmbh
Publication of HU9300069D0 publication Critical patent/HU9300069D0/hu
Publication of HUT64232A publication Critical patent/HUT64232A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
HU9300069A 1992-01-31 1993-01-12 Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it HUT64232A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4202657A DE4202657C2 (de) 1992-01-31 1992-01-31 Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel

Publications (2)

Publication Number Publication Date
HU9300069D0 HU9300069D0 (en) 1993-04-28
HUT64232A true HUT64232A (en) 1993-12-28

Family

ID=6450610

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9300069A HUT64232A (en) 1992-01-31 1993-01-12 Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it

Country Status (19)

Country Link
US (1) US5466451A (hu)
EP (1) EP0553658B2 (hu)
JP (1) JP3611869B2 (hu)
CN (1) CN1074927C (hu)
AT (1) ATE150314T1 (hu)
BR (1) BR9300361A (hu)
CA (1) CA2088289C (hu)
CZ (1) CZ286486B6 (hu)
DE (2) DE4202657C2 (hu)
DK (1) DK0553658T4 (hu)
EG (1) EG20104A (hu)
ES (1) ES2099296T5 (hu)
GR (1) GR3023202T3 (hu)
HU (1) HUT64232A (hu)
MX (1) MX9300265A (hu)
PL (1) PL171097B1 (hu)
RU (1) RU2104017C1 (hu)
SK (1) SK279652B6 (hu)
UA (1) UA26917C2 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695931B1 (fr) * 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
WO1999033463A1 (en) * 1997-12-23 1999-07-08 Moser, René SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b)
DE19800330C2 (de) * 1998-01-07 2002-09-26 Delta 9 Pharma Gmbh Pharmazeutisch wirksamer CO¶2¶-Extrakt aus Tanacetum parthenium
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
GB2340120B (en) * 1998-08-01 2003-06-18 Essential Nutrition Ltd Nettle extract containing phytosterols
DE19844836A1 (de) 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
CN1882354B (zh) * 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
DE102004037002B4 (de) * 2004-07-30 2006-06-14 Chemieanlagenbau Chemnitz Gmbh Verfahren zur Herstellung von Dimethylaminoarglabin-Hydrochlorid
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
US8409637B2 (en) * 2007-06-21 2013-04-02 Puramed Bioscience Inc. Compositions and methods for treating and preventing migrainous headaches and associated symptoms
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119454A1 (de) * 1981-05-15 1982-12-09 Haarmann & Reimer Gmbh, 3450 Holzminden Verfahren zur herstellung von konzentrierten extrakten aus frischen pflanzen oder teilen davon, insbesondere frischen kuechenkraeutern
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB8428747D0 (en) * 1984-11-14 1984-12-27 Hancock K A Products for treatment of human body
FI73962C (fi) * 1985-03-01 1987-12-10 Yhtyneet Paperitehtaat Oy Foerfarande foer framstaellning av vanillin.
FR2629735B1 (fr) * 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
US4996317A (en) * 1988-08-05 1991-02-26 Kraft General Foods, Inc. Caffeine recovery from supercritical carbon dioxide
US5196575A (en) * 1992-02-19 1993-03-23 Hoechst Celanese Corp. Supercritical separation of isomers of functional organic compounds at moderate conditions

Also Published As

Publication number Publication date
ES2099296T3 (es) 1997-05-16
EP0553658A2 (de) 1993-08-04
UA26917C2 (uk) 1999-12-29
EP0553658B2 (de) 2007-02-14
ES2099296T5 (es) 2007-10-16
DE59305824D1 (de) 1997-04-24
ATE150314T1 (de) 1997-04-15
BR9300361A (pt) 1993-08-24
CZ286486B6 (en) 2000-04-12
US5466451A (en) 1995-11-14
DK0553658T4 (da) 2007-03-19
EP0553658B1 (de) 1997-03-19
CA2088289A1 (en) 1993-08-01
EP0553658A3 (hu) 1994-02-16
PL297473A1 (en) 1993-08-09
DE4202657C2 (de) 1995-10-12
JP3611869B2 (ja) 2005-01-19
DK0553658T3 (da) 1997-04-07
HU9300069D0 (en) 1993-04-28
CA2088289C (en) 2002-11-12
MX9300265A (es) 1993-11-01
RU2104017C1 (ru) 1998-02-10
DE4202657A1 (de) 1993-08-05
CZ8293A3 (en) 1993-12-15
EG20104A (en) 1997-07-31
SK279652B6 (sk) 1999-02-11
GR3023202T3 (en) 1997-07-30
SK4693A3 (en) 1993-09-09
CN1074615A (zh) 1993-07-28
JPH0656683A (ja) 1994-03-01
PL171097B1 (pl) 1997-03-28
CN1074927C (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
HUT64232A (en) Process for the production of the medical agent by the extraction from tanacetum parthenium and for the production of medical prepartives containing it
CZ149095A3 (en) Liquid aerosol preparation containing a medicament and stabilization process of said preparation
CA2080223A1 (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
RU93004547A (ru) Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе
EP0125520A3 (en) A process and a plant for the recovery of one or more constituents from a gas mixture
AU8452691A (en) Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
AU604070B2 (en) Modification of alginates or other uronic acid containing compounds
ATE340639T1 (de) Verfahren zur herstellung von teilchen
HU9301990D0 (en) Method for producing inclusion compounds of 5,10-methylene-tetrahydro-folic acid with cyclodextrin
IE873006L (en) Salt of diclofenac with a cyclic organic base and¹pharmaceutical compositions which contain it
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
AU3677589A (en) Pharmaceutical product having epidermial regenerative activity based on the active ingredient of mimosa tenuiflora and process for its obtention
AU7470287A (en) Pharmaceutical compositions with galactitol as carrier
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
ES8400484A1 (es) Un metodo para la extraccion selectiva de 2 acidos del lupulo.
JPS5736958A (en) Deodorizing, processing and preparing technique for making krill into food
SU1715739A1 (ru) Способ переработки шлакового расплава
JPS57125661A (en) Deodorizing method of lime as food additive
JPS6410950A (en) Elimination of taste and odor of substance rich in amino acid
Bernecker Process for Purifying by Distillation Mercury-Containing Materials or Mixed Materials
CA2098224A1 (en) Process for Making Dry Coffee Aroma Oil
JPS52153937A (en) Preparation of novel phenylalanine derivatives
CA2082495A1 (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JPS5592303A (en) Growth accelerator of bean sprout

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): PARRAGH GABORNE DR., S.B.G. & K. BUDAPESTI NEMZETKOEZI SZABADALMI IRODA, HU

Representative=s name: DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEG, HU

FH92 Termination of representative

Representative=s name: PARRAGH GABORNE DR., S.B.G. & K. BUDAPESTI NEM, HU

FD9A Lapse of provisional protection due to non-payment of fees